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 Anemopsis californica is a plant native to the southwestern United States 
and northern Mexico that has been used by many Native American tribes to 
alleviate pain and inflammation and to treat infection.  Limited research has 
examined the chemical composition of A. californica responsible for its purported 
therapeutic properties.  Goal 1 of this study was to identify pathogenic bacteria 
against which the plant extract was active, and isolate the compounds 
responsible for this activity.  Goal 2 was to identify bioactive compounds from 
endophytic fungi isolated from the plant. 
 The A. californica root extract was tested against a panel of bacteria and 
exhibited the most activity against several Mycobacterium spp.  Bioassay-guided 
fractionation was conducted on a sample of A. californica roots was undertaken 
to isolate the bioactive compounds.  These compounds were identified as the 
furofuran lignans sesamin (1) and asarinin (2), which were shown to have 
minimum inhibitory concentrations (MICs) ranging from 23 to 395 µM against five 
different species of environmental nontuberculous mycobacteria.  These findings 
are significant given that these bacteria can cause skin, pulmonary, and 
lymphatic infections.  With the use of liquid chromatography - mass spectrometry 
(LC-MS), it was determined that sesamin and asarinin were extracted at 
relatively high levels from A. californica roots (1.7-3.1g/kg and 1.1-1.7 g/kg, 
respectively), but lower levels from leaves (0.13 g/kg for both compounds).  Our 
 
 
findings suggest that the majority of activity of crude A. californica root extracts 
against nontuberculous mycobacteria can be attributed to the presence of 
sesamin and asarinin.  This is the first reported isolation of these compounds 
from a member of the Saururaceae family, and the first description of their 
activity against nontuberculous mycobacteria. 
 Goal 2 of this project was to identify bioactive compounds from the fungal 
endophytes of A. californica (fungi living asymptomatically within the plant 
tissues).  The fungal endophytes were extracted from the plant and cultured on a 
solid media.  Twelve different fungi were identified.  Crude extracts of these fungi 
were prepared and partitioned with liquid-liquid chromatography. Several 
antimicrobial compounds were isolated or identified from these fungi, including a 
new antimicrobial compound chaetocuprum A from the fungus Chaetomium 
cupreum.  An additional nineteen compounds were also identified, of which six 
have been shown in literature or with our investigations to possess antimicrobial 
activity. In addition, a crude extract of the A. californica root was prepared from 
the same batch of roots from which fungi were isolated, to ascertain whether any 
of these antimicrobial compounds were present in the plant.  None of the 
antimicrobial compounds isolated from the endophytes were detected in the 
extract, but a series of other fungal compounds were present.  Finally, at least 
eighteen ions were detected as being present in both the botanical and fungal 
extracts. The structures of these “overlapping compounds” have not yet been 
 
 
solved, but their presence does suggest a potential role for fungi in the chemical 
composition of botanical extracts.   
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CHAPTER I 
INTRODUCTION 
 One of the largest health threats in the United States is bacterial 
resistance to antimicrobial compounds.  Existing antibiotics are ineffective in 
treating many types of bacterial infections, including some types of mycobacteria, 
Gram-positive bacteria, and Gram-negative bacteria.1  With this research, we 
focused on the identification of compounds from natural product sources effective 
against  representative organisms of all three of these categories.  Due to the 
lack of available antibacterial agents, the challenges to treating these types of 
bacterial infections include increased mortality, increased healthcare costs and 
adverse reactions with long-term antibiotic exposure.   
 Mycobacteria are unique in that they are neither Gram-positive or Gram-
negative.  Non-tubercuclosus mycobacteria (NTM) such as Mycobacterium 
avium and Mycobacterium marinum can have mortality rates up to 25 percent in 
immune-compromised patients, high healthcare costs equivalent to the cost of 
long term HIV treatment, and a 50 percent likelihood of experiencing adverse 
side effects to treatments.2 Mycobacterium species are more likely to infect 
immuno-compromised patients, but have also been seen in immuno-competent 
patients.  Mycobacterial infections are important clinically because of the lack of
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antimycobacterial antibiotics and disinfectants and the emergence of antibiotic-
resistant mycobacteria.3, 4 In addition, both certain types of Gram-positive (such 
as Staphylococcus aureus) and Gram-negative (such as Pseudomonas 
aeruginosa) bacterial infections  can have mortality rates up to 45 percent, and 
the doubling of healthcare costs and the length of stay in the hospital as a result 
of these infections is common.5  Staphylococcus aureus and Pseudomonas 
aeruginosa are major causes of nosocomial (hospital-acquired) wound and 
surgical infections if patients are immuno-compromised or have cystic fibrosis (P. 
aeruginosa).6, 7  Patients often spread S. aureus antibiotic-resistant strains 
quickly in hospitals without effective containment.7  Complications from P. 
aeruginosa infections are often so severe in cystic fibrosis patients that it is one 
of the major causes of death among these patients.8    
 To combat these infections, a new arsenal of antibiotics is needed.  A 
good source for these new antibacterial compounds are the natural products 
made by plants, bacteria, and fungi.  It has been reported that 25 to 50 percent of 
compounds that treat infection have come from these natural sources.9  With this 
project, the purpose is to identify new antimicrobial agents from a botanical and 
its endophytic fungi useful against several species of pathogenic bacteria, 
Mycobacterium spp., Staphylococcus aureus, and Pseudomonas aeruginosa. 
This project is significant to public health because it investigates new 
antimicrobial agents from A. californica that could decrease the time, cost, and 
adverse side effects involved in bacterial treatment.  
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 Many Native American tribes in the Southwestern United States have 
used a plant named Anemopsis californica or yerba mansa to ease pain, 
decrease inflammation and to treat infection.  Anemopsis californica is a member 
of the Saururaceae family, and is a popular groundcover for parks in the 
southwestern United States and phytoremediatior of arsenic from groundwater 
and soil.10  It is also a plant that has been used in traditional medicine by different 
cultures in the U.S. and Mexico for hundreds of years.  Both the leaves and roots 
were used as antiseptic salves for wounds, boiled as tea or used orally for 
internal ailments.11, 12 The specific ailments this plant was used for include cold 
and flu, venereal diseases, inflammation, and pain.11 Today A. californica is 
widely used as a part of traditional /alternative medicine in the Southwestern 
United States, and it is usually sold either as dry or ethanolic extracts of the 
leaves and roots.13 
Although ethnobotanical literature shows the use of whole plant A. 
californica extracts for treatment of infection, the majority of prior research on this 
botanical has focused on its essential oil.  Studies have shown that the 
constituents contained in the A. californica root/rhizome essential oils were 
mainly classified as monocyclic and bicyclic monoterpenoids and 
phenylterpenoids.13, 14 These compounds were active against AN3CA 
(endometrial cells) and HeLa (cervical cells) cancer cells in vitro.13, 14 Another 
group showed that the crude ethanol and the crude ethylacetate extracts of the 
A. californica root can affect the proliferation and migratory-ability of colon cancer 
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cell line HCT-8, and the breast cancer cell lines Hs 578T and MCF-7/AZ.15 Some 
of the same chemical compounds identified as monocyclic and bicyclic 
monoterpenoids and phenylterpenoids in the essential oil of the A. californica 
roots were also found in the essential oil of the leaves.16   
 With this research, we sought to provide more information about the 
compounds responsible for purported effectiveness of A. californica against 
infection.  Project 1 focused on identifying antimicrobial compounds in the A. 
californica plant, and then quantifying them in the different plant parts.  With 
project 2, we sought to isolate and identify antimicrobial compounds from A. 
californica endophytic fungi (fungi isolated from the plant roots) and to determine 
whether fungal compounds could be identified in an A. californica botanical 
extract.  
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CHAPTER II 
ISOLATION OF SESAMIN AND ASARININ 
     Chapter II is based in part on data published previously in the journal Planta 
     Medica:  Bussey III, R. O.; Sy-Cordero, A. A.; Figueroa, M.; Carter, F. S.; 
     Falkinham III, J. O.; Oberlies, N. H.; Cech, N. B., Antimycobacterial Furofuran 
     Lignans from the Roots of Anemopsis californica. Planta Med 2014, 80 (6), 
     498-501. 
Introduction 
 A new arsenal of antibiotics is needed to address two problems involving 
treatment of bacterial infections: the emergence of drug-resistance and the 
existence of bacteria that are innately resistant to most antibiotics.  A promising 
source for new antibacterial compounds is the natural products produced by 
plants, bacteria, and fungi.  It is estimated that 25 to 50 percent of anti-infective 
agents come from these natural sources.9  This study chose the plant Anemopsis 
californica (Nutt.) Hook. & Arn. (Saururaceae) as a potential source of 
antimicrobial compounds. 
 Anemopsis californica, commonly known as "yerba mansa," is native to 
the southwestern United States and northern Mexico, and its roots, leaves, and 
stem have been used medicinally by many Native American tribes.17-19 Despite 
historical and modern precedent for the use of this plant to treat infection,
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only a few studies have focused on the chemicals responsible for its anti-infective 
properties.16, 20  The chemical compounds identified from A. californica thus far 
are exclusively from the volatile oils of the leaves and roots.13, 14 Volatile oil 
extracts from A. californica have been shown to inhibit the growth of endometrial, 
cervical, colon, and breast cancer cells in vitro,13, 14 and demonstrated 
antimicrobial activity against Staphylococcus aureus, Streptococus pneumoniae, 
and Geotrichim candidum.16 Additionally, ethanol and ethyl acetate extracts of 
various parts of A. californica were shown to inhibit the growth of colon and 
breast cancer cells, and aqueous A. californica extracts inhibited cell migration 
and metastasis.15, 21 These studies did not indicate which chemical constituents 
of those extracts were responsible for the observed effects. 
 There are currently no reports of the identities of non-volatile compounds 
present in A. californica roots and leaves.  This is a significant gap in the 
literature, given that its traditional mode of application of A. californica is a whole 
plant poultice or decoction.  For example, the Shoshoni tribe of Nevada applied 
boiled and mashed A. californica roots to areas of inflammation and infections.17 
The Pima tribe of Arizona and New Mexico and the Mahuna and Chumash tribes 
of California used a decoction of leaves and roots to treat wounds,18, 22 and the 
Nevada Paiute and the California Costanoan tribes used decoctions of A. 
californica roots or leaves to treat pain.17, 19  
 The ethnobotanical precedent for application of A. californica to treat 
infections encouraged us to screen extracts from this plant for activity against 
7 
 
pathogenic microorganisms.  Activity of crude A. californica extracts was noted 
against several species of nontuberculous mycobacteria.  These findings were 
deemed significant, given the clinical relevance these organisms.  
 Nontuberculous mycobacteria are commonly found in soils, natural 
waters, and engineered water systems, including household plumbing,23 and can 
cause pulmonary, skin, and lymph node infections.24 The resultant chronic 
respiratory or soft tissue infections require long term antibiotic treatment that can 
have serious side effects.25 Current estimates report a total number of over 
16,000 cases in the United States of nontuberculosis mycobacterial disease per 
year with a total cost of over $425 million.26 The objective of this research was to 
identify compounds from A. californica with potential for the treatment of 
nontuberculous mycobacterial infections.  In addition, we sought to provide 
insight into the scientific basis for the ethnobotanical use of A. californica to treat 
bacterial infections.
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Results and Discussion 
 Bioactivity-guided fractionation of A. californica resulted in the isolation of 
two compounds, sesamin (1)27 and its C-7 epimer, asarinin (2). 
 Sesamin was a white solid with a HRESIMS m/z of 355.1175  (calcd for 
C20H19O6 [M+H]
+ m/z 355.1176, 25
D
= + 104, c = 0.0125 g/100 mL, methanol). 
Asarinin, also called episesamin or isosesamin,  was a white solid with a 
HRESIMS m/z of 355.1167 (calcd for C20H19O6 [M+H]
+ m/z 355.1176, 25
D
= + 
144, c = 0.0125 g/100 mL, methanol).  The 1H and 13C NMR of both sesamin and 
asarinin were in agreement with literature values.28 1H and 13C NMR data plus 
spectra are included for reference on the successive pages (Table 1 and Figures 
2-5). 
 
 
Figure 1. Structures of furfuran lignins sesamin (1) and asarinin (2) isolated from 
Anemopsis californica. 
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Table 1.  NMR spectroscopic data (500 MHz for 1H and 125 MHz for 13C, CDCl3) for 
sesamin (1) and asarinin (2) from A. californica. 
 
 sesamin  asarinin 
Position 
δH mult. 
(J in Hz)H 
δC Position 
δH mult. 
(J in Hz)H 
δC 
1, 1'  135.0 C 1  135.1 C 
   1'  132.3 C 
2, 2' 6.84, s 106.6 CH 2 6.86, s 106.5 CH 
   2'  106.7 CH 
3, 3'  148.1 C 3  147.3 C 
   3'  148.0 C 
4, 4'  147.2 C 4  146.6 C 
   4'  147.7 C 
5, 5' 6.77, d (8.0) 108.3 CH 5 6.81, m 108.3 CH 
   5'  108.3 CH 
6, 6' 
6.80, dd (8.0, 
1.7) 
119.5 CH 
6 
6.81, m 119.7 CH 
   6'  118.8 CH 
7, 7' 4.71, d (4.0) 85.9 CH 7 4.82, d (5.0) 87.7 CH 
   7' 4.39, d (7.0) 82.1 CH 
8, 8' 3.05, m 54.4 CH 8 3.3, m 54.7 CH 
   8' 2.85, m 50.2 CH 
9, 9' 4.2, dd  
(9.2, 6.9) 
3.9, dd  
(9.2, 3.9) 
71.8 CH2 9 
 
9' 
3.81, m; 4.09, 
d (9.5) 
3.3, m; 3.81, m 
69.8 CH2 
71.0 CH2   
10, 10' 5.95, s 101.2 10 5.97 s 101.1  OCH2O 
  OCH2O 10' 5.95 s 101.3  OCH2O 
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Figure 2. 1H NMR spectrum (500 MHz in CDCl3) for sesamin (1) from Anemopsis 
californica. 
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Figure 3. 1H NMR spectrum (500 MHz in CDCl3) for asarinin (2) from Anemopsis 
californica. 
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Figure 4. 13C NMR spectrum (125 MHz in CDCl3) for sesamin (1) from A. 
californica. 
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Figure 5. 13C NMR spectrum (125 MHz in CDCl3) for asarinin (2) from A. 
californica. 
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 Although sesamin and asarinin are both known compounds, this is the first 
report of their presence in a member of the Saururaceae plant family.  Sesamin 
was first isolated from sesame seed oil, 29, 30 while asarinin was first isolated from 
prickly ash bark.31 Both sesamin and asarinin have been shown to act as 
insecticidal synergists with pyrethrins.30 Previous studies have shown that 
sesamin has moderate activity against S. aureus and no activity against E. coli.32 
In addition, asarinin was shown to be moderately active against S. aureus and B. 
subtilis, and it was suggested that it inhibits the NorA efflux pump system of S. 
aureus. 33 
 Sesamin and asarinin demonstrated a range of antimicrobial activities (8 
to 140 µg/mL or 22.6 µM to 395 µM) against the five different species of 
Mycobacterium evaluated (Table 2).   
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 This is the first report of activity of sesamin and asarinin against 
nontuberculous mycobacteria, although both sesamin and asarinin were shown 
to lack activity against M. tuberculosis.34 These results are not surprising, given 
that members of the M. tuberculosis complex do not share the same 
susceptibilities to anti-mycobacterial antibiotics with the nontuberculous 
mycobacteria.25 
 Crude A. californica extracts were tested against representative 
Mycobacterium species (Table 2). Samples 1 and 3 (root extracts) demonstrated 
 
Table 2. Minimum inhibitory concentrations (MIC) of crude extracts of A. 
californica, sesamin, and asarinin against Mycobacterium species. 
   
Sample MIC (µg/mL) Against: 
 
M. 
smegmatis 
M. 
abscessus 
M. 
chelonae 
M. 
marinum 
M. avium A5 
Sample 1a 125 >250 >250 250 125 
Sample 2a >250 >250 >250 >250 >250 
Sample 3b 125 >250 250 >250 >250 
Sesamin 8 >130 65 13 8 
Asarinin 35 >140 140 35 35 
Rifampinc 25 0.8 0.15 0.8 2 
 
aSamples 1 and 2 are for root and aerial extracts-respectively from the same 
A. californica plant. 
bSample 3 represents a large batch root extract that was subjected to 
bioactivity-directed fractionation, resulting in the isolation of sesamin and 
asarinin.  
cThe antibiotic rifampin is included as a positive control.  Negative control 
(vehicle, 2% DMSO) caused no significant growth inhibition.   
d These data were collected by our collaborators in the laboratory of    Dr. 
Joseph O. Falkinham at Virginia Polytechnic University. 
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MIC values ranging from 125 to >250 µg/mL, while sample 2 (aerial extract) 
demonstrated weak or no inhibition (MIC >250 µg/mL).  These differences in 
activity were likely due to the higher levels of sesamin and asarinin present in 
roots as compared to leaves (Table 3). 
Table 3.  Quantity of sesamin and asarinin in extracts prepared from roots or 
leaves/stems of A. californica 
 
Sample 
Name 
Plant part 
Sesamin 
Concentrationa 
Asarinin Concentration 
yieldb  
(ppt) ± SD
% in 
extractc   
± SD 
yield  
(ppt) ± SD 
% in extract  
± SD 
Sample 
1 
Root 3.1 ± 0.3 8.8 ± 1.0 1.7 ± 0.1 4.7 ± 0.4 
Sample 
2 
Leaf/stem 
0.13 ± 
0.02 
0.95 ± 0.14 0.13 ± 0.02 0.9 ± 0.2 
Sample 
3 
Root 1.7 ± 0.2 8.8 ± 0.9 1.1 ± 0.1 5.9 ± 0.2 
a 
Concentrations were determined by LC‑MS analysis of extracts prepared from 
the relevant plant parts. Standard deviations are for triplicate analyses of the 
same extract. Extract concentration was calculated based on linear regression 
analysis of 6 point calibration curves of peak area versus concentration with 
slope (m) = 587881 ± 4628, intercept (b) = -20512 ± 10554, and R2 = 0.9998 
for sesamin and a slope (m) = 647726 ± 16450, intercept (b) = -15594 ± 
37516, and R2 = 0.9974 for asarinin.  Extracts were diluted so that the 
concentrations tested fell within the linear range of the calibration curve.  
bYield is reported as parts per thousand or mass of pure compound (g) per 
mass of original plant material (kg).  
c% in extract is reported as mass (g) of sesamin or asarinin per mass of solid 
extract (g) × 100.  The % in extract values are provided for the purpose of 
comparison with biological data. 
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 The root extracts (samples 1 and 3) were notably less active compared to 
the pure compounds.  However, these extracts are crude mixtures, and sesamin 
and asarinin constituted only a fraction of their content (Table 3).  Accounting for 
this difference, it appeared that the antimycobacterial activity of the crude 
extracts could be largely attributed to the presence of sesamin and asarinin.  For 
example, sample 1, a root extract of A. californica, demonstrated an MIC of 125 
µg/mL against M. smegmatis (Table 2).  Sample 1 contained 8.8 ± 1.0 % 
sesamin and 4.7 ± 0.4 % asarinin (Table 3); thus, the MIC of 125 µg/mL 
(expressed as mass of crude extract/volume media) is equivalent to 16.8 µg/mL 
(expressed as mass of sesamin and asarinin, combined, per volume of media).  
This value is within the range of the reported MICs for sesamin and asarinin 
alone against M. smegmatis (8 and 35 µg/mL, respectively).   
 In conclusion, the results of the quantitative analysis suggest that the 
majority of activity of A. californica root extracts against nontuberculous 
mycobacteria can be attributed to the presence of relatively high levels of 
sesamin and asarinin.   Importantly, the presence of anti-mycobacterial 
compounds in A. californica roots supports the traditional use of this plant as a 
treatment for infection, although follow up studies would be necessary to 
evaluate the in vivo relevance of these findings.  The higher levels of sesamin 
and asarinin in roots over leaves suggest that root extracts may be more 
effective than leaf extracts for treatment of mycobacterial infections.   
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Materials and Methods 
 Plant Material   
 Cultivated Anemopsis californica plant material was obtained from two 
sites, Horizon Herbs in Williams, OR (42°12' 17.21"N, 123°19' 34.61"W; voucher 
number NCU592735, identified by Richard A. Cech) and Apache Creek Ranch in 
Santa Fe, NM (35°35' 56.40"N, 105°50' 27.22"W; voucher number NCU602027, 
identified by Amy Brown).  Vouchers are retained at the University of North 
Carolina Herbarium.  Harvested plant material was separated into three different 
portions, a root sample (sample #1, 9.8 g dry weight), a leaf/stem sample from 
the same plant (sample #2, 7.5 g dry weight, both harvested from Horizon Herbs 
in April, 2010), and a large batch of roots/rhizomes to facilitate isolation work 
(sample #3, 520 g dry weight) harvested from Apache Creek Ranch in November 
2010.  All plant material was air dried prior to extraction. 
 Extraction and Liquid Chromatography-Mass Spectrometry 
 Three batches of A. californica plant material were cut and ground, and 
then were macerated in methanol for 24 hours.  The marc for each extract was 
subsequently soaked in methanol a total of three times, and the methanol was 
decanted and combined.  The methanol extracts were evaporated to dryness 
with a rotary evaporator and subjected to liquid-liquid partitioning using published 
methods. 35  Briefly, the methanol extract was defatted by partitioning between a 
1:1 ratio of hexane to methanol, and the latter fraction was then dried down and 
further partitioned between 4:1:5 of chloroform:methanol:water. The chloroform 
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fraction was evaporated to dryness and its antimicrobial activity was tested using 
a broth microdilution assay. The yields from the chloroform fraction of samples 1, 
2, and 3 were 343 mg, 104 mg, and 10 g, respectively. 
 For the isolation of the active compounds, the chloroform extract (10 g, 
sample #3, roots and rhizomes) was subjected to two stages of normal-phase 
chromatography on a CombiFlash®Rf ISCO using RediSep Rf Gold® Silica 
Columns (Teledyne ISCO, Lincoln, NE, USA).  The first stage of normal-phase 
chromatography was performed with a hexane/chloroform/methanol gradient on 
silica gel (20-40 µm particle diameter, 120 g column, eluent chloroform and 
methanol, flow rate 18 mL/min) and the eluate was pooled into 12 fractions.  
Fraction VI (360-450 mL, 645 mg) was subjected to a second stage of separation 
with a hexane/acetone/methanol gradient on silica gel (20-40 µm particle 
diameter, 120 g column, eluent acetone and methanol, flow rate 18 ml/min) and 
pooled into 10 fractions.   Fraction V (250-320 mL, 420 mg), the active fraction, 
was then subjected to further purification with two successive stages of isocratic 
separation with reversed-phase preparative HPLC on a C18 column 
(Phenomenex, Gemini-NX, 5 µm, 250  21.2 mm, flow rate 21 mL/min).  The first 
stage of reversed-phase separation employed a 50:50 acetonitrile:water isocratic 
mobile phase composition, and the eluate was pooled into 5 fractions.  Fractions 
II and III from this separation (200-300 mL and 320-400 mL, 75 mg and 80 mg, 
respectively) were then combined and subjected to a second reversed-phase 
separation with an isocratic mobile phase composition of 75:25 methanol:water.  
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Sesamin (1) (0.012 % yield, 60 mg, 98.3% purity) eluted at 15 min and asarinin 
(2) (0.0096% yield, 60 mg, 98.5% purity) eluted at 16.5 min. 
 Test Bacteria, Chemicals, Biochemicals, and Minimal Inhibitory   
     Concentration 
 
 Mycobacterium marinum (ATCC strain 927), M. smegmatis strain mc2155 
(ATCC strain 700084), M. abscessus strain AAy-P-1, M. chelonae strain EO-P-1, 
M. intracellulare strain TMC 1406T (ATCC 13950), and M. avium strain A5 4, 36 
were grown in Middlebrook 7H9 broth medium containing 0.5 % (v/v) glycerol 
and 10 % (v/v) oleic acid-albumin with aeration (120 rpm) for 7 days at 37°C or 
30°C (only M. marinum).  Minimal inhibitory concentration (MIC) of each fraction 
or compound was measured by broth microdilution with a starting inoculum of 
0.5-1.0 ×105 CFU/mL.4, 37 The plates were incubated for 4 days at 37°C or 30° C 
(only M. marinum) and the turbidity measured (absorbance 580 nm). Extracts 
were tested over a concentration range of 0.12 to 250 µg/mL by two-fold 
dilutions, in the presence of a constant DMSO concentration (2%).  The MIC was 
defined as the lowest concentration completely inhibiting bacterial growth.  
Rifampin (Sigma, St. Louis, MO purity ≥ 97%) served as the control. 
 Quantitative Analysis 
 Sesamin and asarinin were identified in the crude A. californica extracts by 
matching retention time and fragmentation patterns with those of the isolated 
standard compounds.  The concentrations of these compounds were then 
measured using selective reaction monitoring (SRM) on a triple quadrupole mass 
spectrometer (TSQ Access; Thermo Scientific, Waltham, MA, USA) with an 
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electrospray ionization source in the positive ion mode.  Transitions of 337.1 to 
203.1 and 337.1 to 289.2 were employed for the isomeric compounds.  The mass 
spectrometer was coupled to a reversed phase high performance liquid 
chromatograph (HPLC) (Agilent HP1200; Santa Clara, CA, USA) with a PFP 
column (5 µm, 150  4.6 mm; Phenomenex, Torrance, CA, USA).  An acetonitrile 
(1% formic acid):water (1% formic acid) gradient was employed at 1.0 mL/min 
with HPLC grade solvents. A calibration curve (concentration range of 0.05 to 5.0 
µg/mL) of concentration versus average peak area for triplicate injections was 
employed for quantitative analysis.  Extracts were diluted so that sesamin and 
asarinin concentrations fell within the linear range of the calibration curve. 
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CHAPTER III 
ANTIMICROBIAL ENDOPHYTES FROM A BOTANICAL TRADITIONALLY 
USED TO TREAT INFECTION, YERBA MANSA  
(ANEMOPOSIS CALIFORNICA) 
     Chapter II is based in part on data in preparation to be submitted for  
     publication in the Journal of Natural Products: Bussey III, R.; Kaur, A.; Todd, 
     D.; Egan, J.; El-Elimat, T.; Graf, T.; Raja, H.; Oberlies, N.; Cech, N., 
     Antimicrobial Endophytes from a Botanical Traditionally Used to Treat 
     Infection, Yerba Mansa (Anemoposis californica). Journal of Natural Products 
     2014, in preparation. 
Introduction 
 Recent investigations have pointed to the importance of endophytes 
(microscopic organisms living asymptomatically within plant tissues) for 
influencing the metabolite profile of plants.  With this study, we investigated 
endophytes of the botanical yerba mansa [Anemopsis californica (Nutt.) Hook. & 
Arn. (Saururaceae)].  Yerba mansa has been traditionally used by people of 
Mexico and the southwestern United States as a topical treatment for infection.  
Thus, we hypothesized that this plant would harbor endophytes with antimicrobial 
activity.  Endophytes were cultured and extracted.  Many of these extracts 
exhibited antimicrobial effects against Staphylococcus aureus and, to a lesser 
extent, Pseudomonas aeruginosa.  A number of known compounds, including 
several with antimicrobial activity, were identified from the various fungal 
extracts.  Additionally, the new spirolactone, chaetocuprum A (3) was 
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isolated as a secondary metabolite of the fungus Chaetomium cupreum.  
Spirolactones are relatively uncommon in the natural products literature, and this 
is the first report of isolation of such a compound from the genus, Chaetomium.  
Our investigations indicate endophytic fungi from yerba roots to be a potentially  
rich source of antimicrobial compounds.  However, the relevance of this finding to 
ethnobotanical use of A. californica remains unproven.  Our study showed very 
different endophyte profiles for A. californica plants grown under different 
conditions (field versus greenhouse).  Since the endophytes present in this plant 
may be more reflective of the growing environment than the species itself, 
additional studies from different geographical locations may be necessary to 
predict the presence of obligate endophytes and their affect on the antimicrobial 
properties of yerba mansa.   Thus our studies still point to the importance of 
considering growing conditions when pursuing natural product drug discovery 
from endophytic fungi. 
 Historically, it has been assumed that the biologically active agents of 
plant-based medicines are plant secondary metabolites.  However, plants are 
teeming with microbial symbionts, including endophytes; microbes that live 
asymptomatically within plant tissue.  Endophytes can produce an array of 
biologically active secondary metabolites, and the potential influence of these 
compounds on the biological activity of botanicals has been a topic of a great 
deal of recent interest.  It has been determined that some compounds originally 
believed to be of botanical origin are actually produced by fungal endophytes.  
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For example, endophytic fungi play a role in the production of hallucinogenic 
ergot alkaloids in morning glories (genera Ipomoea)38 and ergot and insecticidal 
loline alkaloids in tall fescue grass (genera Festuca and Lolium).39 To further 
complicate matters, gene transfer can occur between plants and endophytes, 
such that microbes may acquire the ability to produce the same compounds 
originally produced by the host plant, or vice versa.40 Additionally, the presence 
of particular microbes may alter the growth and/or secondary constituent profile 
of the host plant.41 In light of this, it is becoming increasingly apparent that 
endophytes should be considered when investigating the biological activity of a 
particular botanical. 
 In order to understand more about the importance of endophytes and its 
contribution to the biological activity of a plant-based medicine, more needs to be 
known about endophytes.42  Horizontally transmitted endophytes, on the other 
hand, may be more representative of the environment surrounding the plant than 
of the particular plant species.  Because of horizontal endophyte transmission, it 
is likely that the same genus and species of a plant grown in different 
environments can have very different endophyte profiles.43 Furthermore, if the 
endophytes produce biologically relevant levels of medicinally active compounds, 
it is possible that the medicinal activity of the same plant species could be 
different depending on environment.  Thus, environmental endophyte profile 
could be either a beneficial or confounding factor in experiments screening for 
biological activity of botanical extracts. 
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 With this study, we focused on fungal endophytes from the botanical 
medicine Anemopsis californica (Nutt.) Hook. & Arn. (Saururaceae), which is 
commonly known as yerba mansa.  Anemopsis californica was used by the 
Shoshoni, Pima, Mahuna, Chumash, Paiute, and Costanoan tribes to treat 
inflammation and infection in wounds, and to control pain.17-19, 22 This plant is still 
used today for the treatment of infections, and although it has been sparsely 
studied, there are several reports of antimicrobial16, 44 or cytotoxic15, 21 activity 
associated with A. californica extracts or constituents. 
 Thus far, there have been no investigations of the endophyte profile of A. 
californica plants, or the possible contribution of endophytes to its biological 
activity.  Anemopsis californica is traditionally used topically as a poultice or 
decoction applied to the afflicted area.  This practice almost certainly results in 
the application of compounds of both botanical and microbial origin.  With this 
research, we hypothesized that A. californica, a plant used to treat infection, 
would harbor endophytes with antimicrobial activity.  The goals of this project 
were 1. to identify antimicrobial compounds from A. californica endophytes; 2. to 
identify compounds of fungal origin in A. californica extracts; and 3. to evaluate 
the possible overlap in chemistry between extracts of A. californica roots and 
their associated endophytes.  We also compared endophyte profiles in A. 
californica plants that were grown under different conditions. 
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Results and Discussion 
 Influence of Environment on Fungal Diversity 
 The first question we sought to answer in this project was whether 
changes in growing conditions would alter the endophyte profile of A. californica 
plants.  Given the commonness of horizontal transmission, we expected that this 
would be the case.  To test this experimentally, we isolated endophytes from two 
different batches of A. californica roots (Figure 6) to obtain the data in Table 4.  
One batch of roots was wild-harvested directly from a field plot and the other 
batch of roots came from the same field plot sample but was allowed to grow in a 
greenhouse for one year prior to being harvested (Figure 6).  The difference in 
diversity of the fungal collections from the field and greenhouse samples is 
striking.  The field samples yielded a diverse array of at least ten distinct fungal 
endophytes (Table 4).  In stark contrast, the roots that had grown for one year in 
the greenhouse yielded only two fungal species, Phomopsis columnaris and 
Ilyonectria robusta.  Both of these fungal species have been known to infect and 
kill plants by either causing root rot (I. robusta) or stem death (P. columnaris).45 
Interestingly, P. columnaris was the only fungus found to be present in both the 
field samples and the greenhouse samples.  This fungus was isolated only once 
from the field samples, but repeatedly (10 times) from the greenhouse samples.  
Our data suggest that cultivation in the greenhouse for one year caused a loss in 
fungal richness in the A. californica root samples, with an apparent shift towards 
pathogenic fungal species in the soil.  This finding is relevant to natural products 
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drug discovery because it shows that the diversity of fungal endophytes obtained 
from botanical samples can vary greatly depending on environment/method of  
cultivation. 
 
 
Figure 6.  Overview of the experimental design for collection of plants for 
endophyte collection. Plant picture provided by USDA, The PLANTS Database, 
Greensboro, NC.  
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Table 4.  Antimicrobial activity and identity of fungal endophytes isolated from Anemopsis 
californica roots.  Growth inhibition is expressed as the mean decrease in absorbance at 
600nm for triplicate cultures (± standard deviation, SD), as described in Methods. 
 
Batch 1 (field samples) 
Fungal species 
 
Fungal ID 
number 
S. aureus growth 
inhibition at 
20 µg/mL (%) 
S. aureus growth 
inhibition at 
200 µg/mL (%) 
P. aeruginosa 
growth inhibition at 
200 µg/mL (%) 
Hypocreales sp. G115 16 ± 1.0 0 ± 1.0 12 ± 1.0 
Chaetomium cupreum G118 26 ± 1.5 35 ± 2.0 79  ± 3.0 
Cylindrocarpon sp. G136 13 ± 1.0 100 ± 1.0 13 ± 1.0 
Aspergillus sp. G124 37 ± 1.7 28 ± 1.9 15 ± 1.3 
Penicillium sp. G114 21 ± 1.7 0  ± 1.0 29 ± 2.7 
Cylindrocarpon sp. G116 42 ± 1.0 37 ± 1.7 15 ± 2.4 
Cylindrocarpon sp. G121 37 ± 1.0 24 ± 1.0 32 ± 1.0 
Cylindrocarpon sp. G120 58 ± 2.5 63 ± 4.0 37 ± 2.0 
Phomopsis columnaris G117 49 ± 1.0 13 ± 1.0 17 ± 1.0 
Fusarium sp. G134 9 ± 1.0 28 ± 1.0 9 ± 1.0 
Colletotrichum 
coccodes 
G112 31 ± 1.0 48 ± 3.4 9 ± 1.0 
Colletotrichum 
coccodes 
G113 36 ± 3.0 0 ± 1.0 13 ± 1.0 
Fusarium sp. G137 40 ± 3.0 15 ± 1.0 21 ± 1.0 
Penicillium sp. G135 42 ± 2.0 42 ± 2.7 0 ± 1.0 
Penicillium sp. G144 0 ± 1.0 64 ± 2.3 38  ± 6.3 
Hypocreales sp. G151 0 ± 1.0 0 ± 1.0 14 ± 1.0 
Batch 2 (greenhouse samples) 
Fungal species 
 
Fungal ID 
number 
S. aureus growth 
inhibition at 
20 µg/mL (%) 
S. aureus growth 
inhibition at 
200 µg/mL (%) 
P. aeruginosa growth 
inhibition at 
200 µg/mL (%) 
Phomopsis columnaris G212 16 ± 1.0 100 ± 5.0 10 ± 2.0 
Phomopsis columnaris G215 0 ± 1.0 34 ± 2.3 9 ± 1.0 
Phomopsis columnaris G220 19 ± 2.0 53 ± 2.0 18 ± 1.0 
Ilyonectria robusta G213 0 ± 1.0 0 ± 1.0 0 ± 1.0 
Phomopsis columnaris G221 28 ± .0 49 ± 2.0 7 ± 1.0 
Phomopsis columnaris G217 0 ± 1.0 0 ± 1.0 10 ± 1.0 
Phomopsis columnaris G223 17 ± 3.0 93 ± 3.7 34 ± 4.0 
Phomopsis columnaris G216 0 ± 1.0 43 ± 2.0 6 ± 1.0 
Phomopsis columnaris G222 0 ± 1.0 57 ± 1.7 12 ± 1.0 
Phomopsis columnaris G218 0 ± 1.0 17 ± 1.5 31 ± 4.0 
Phomopsis columnaris G214 0 ± 1.0 0 ± 1.0 5 ± 1.0 
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 Antimicrobial Activity of A. californica Endophytes and their 
                Constituents 
 To test the prediction that A. californica would harbor antimicrobial fungi, 
all of the fungal isolates obtained from both batches of A. californica roots were 
extracted and their ability to inhibit the growth of several bacterial species was 
measured (Table 4). Several of the fungal extracts inhibited growth of 
Staphylococcus aureus ((NCTC8325-4) by at least 50% at a concentration of 200 
µg/mL.  These were: Cylindrocarpon sp. (G136, G120), Penicillium sp. (G144), 
and Phomopsis columnaris (G212, G220, G222, and G223).  In addition, several 
fungal isolates demonstrated weak activity (growth inhibition ≥ 30%) against 
Pseudomonas aeruginosa (NCTC 12903) at a concentration of 200 µg/mL.  
These were: Chaetomium cupreum  (G118), Cylindrocarpon sp. (G121, G120), 
Penicillium sp. (G144), and Phomopsis columnaris (G218 and G223).  It is well 
known that the Gram-negative bacteria P. aeruginosa is less susceptible to 
antimicrobial agents than Gram-positive bacteria, so the observation that activity 
against P. aeruginosa was less pronounced is not surprising.46 
 The data in Table 1 show that A. californica harbors fungi that produce 
antimicrobial compounds.  We sought to identify some of these.  Our isolation 
efforts focused specifically on the endophytes Chaetomium cupreum (G118) and 
Cylindrocarpon sp. (G120) because extracts of these fungi demonstrated the 
most antimicrobial activity against P. aeruginosa.  One new compound, a 
spirolactone that we have named chaetocuprum A (3), was isolated from 
Chaetomium cupreum and its structure solved (see the next section for details on 
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structure elucidation).  This compound demonstrates some structural similarities 
to the fungal secondary metabolite Compound C (US patent # 5,064,856) (4), 
which has previously been isolated from the fungus Pseudoarachniotus roseus.47 
Secondary metabolite production by the genus, Chaetomium has been 
investigated previously48 but this is the first time a spirolactone has been isolated 
from this genus.  In the literature, there are a few examples of natural products 
containing spirolactone ring systems such as spiromamakone A, aranorosinols, 
and melettinins.49, 50 
 
 
 
 
 
 
 
 
 
 
 
 
                             3 
                             4 
 
Figure 7. Structures of spirolactones chaetocuprum A (3) 
isolated from Chaetomium cupreum and compound C 
(US Patent # 5,064,856) (4) isolated by Merck & Co., Inc. 
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 The known compounds including cochliodone A (5), equisetin (6), 5'-
epiequisetin (7), palmitic acid (8) and ergosterol peroxide (9) were all isolated as 
part of our studies.  Compounds 5 and 9 were isolated from Chaetomium 
cupreum, and compounds 6-9 were isolated from Cylindrocarpon sp (G120).  
Cochliodone A (5) has been previously isolated from the Chaetomium 
cochliodes, but this is the first time it has been isolated from Chaetomium 
cupreum.51  This is also the first report that equisetin (6) and its epimer 5'-
epiequisetin (7) are produced by the Cylindrocarpon genus.  Palmitic acid (8)52, 53  
and ergosterol peroxide (9)54 are both highly ubiquitous compounds in nature.53-
56  
 
   5    6    7 
 
                               8                   9 
 
Figure 8. Compounds isolated from A. californica fungal endophytes 
cochliodone A (5), equisetin (6), 5’-epiequisetin (7), palmitic acid (8), 
ergosterol peroxide (9). 
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 As a complementary approach to the isolation and identification of the 
chemical constituents in endophyte extracts, all extracts were subjected to LC-
MS-MS analysis and the data were compared to a library of high-resolution mass 
spectrometry data on fungal compounds as described previously.57 Using this 
approach, fourteen additional known compounds (10-23) were tentatively 
identified (figures 9 and 10), and several of the compounds isolated from 
Cylindrocarpon sp. were detected in other fungi.  (See Table 5 for the names of 
the compounds and associated fungi from which they were identified.)  The 
literature shows that some of these compounds (10 and 11) possess 
antimicrobial activity.  Verticillin A (10), identified from Hypocreales sp., has 
previously been shown to inhibit the growth of Gram-positive bacteria such as 
Bacillus subtilis, Bacillus anthracis, S. aureus, and Mycobacterium tuberculosis.58 
The acremoxanthone acremonidin C (11), an anthraquinone–xanthone 
heterodimer, had strong activity against S. aureus and B. cereus and weak 
activity against C. albicans and Plasmodium falciparum.59  Thus, the detection of 
these compounds in the fungal isolates lends support to the hypothesis that 
antimicrobial compounds are produced by A. californica endophytes. 
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Figure 9. Compounds from A. californica fungal endophytes tentatively 
identified by matching LC/MSMS fragmentation patterns with a database of 
high resolution mass spectrometry data on pure fungal compounds. 
verticillin A (10), acremonidin C (11), apicidin (12), 11’-deoxyverticillin (13), 
trichothecinol B (14), AGI-7 (15), chermesinone A (16), (E)-8-(3-(oct-2-
enoyl)oxiran-2-yl)octanoic acid (17), 5,8-Epidioxyergosta-6,9(11),22-trien-3-
ol (18). 
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Table 5.  List of endophytic fungal species isolated from Anemopsis californica roots 
and chemical compounds identified from each fungal species.  Batch 1 consists 
plants harvested from a field plot, batch 2 are the same population of plants 
transferred to a greenhouse and cultivated there for one year prior to harvest. 
 
Batch 1 (field samples) 
OTU identification Fungal ID Compounds identified 
Colletotrichum 
coccodes 
G112, G113  
Penicillium sp. G114  
Hypocreales sp. G115 
verticillin A (10), 11-deoxyverticillin 
A (13) 
Cylindrocarpon sp. 
G116, G119, G120, 
G121, G136 
equisetin (6), 5’-epiequisetin (7), 
palmitic acid (8) 
Chaetomium cupreum G118 
chaetocuprum A (3), cochliodone A 
(5), ergosterol peroxide (9) 
Aspergillus sp. G124  
Fusarium sp. G134, G137 apicidin (12) 
Penicillium sp. G144, G145  
Herpotrichiellaceae sp. G146  
Sordariales sp. G149  
Penicillium sp. G148, G150  
Hypocreales sp. G151  
Nemania serpens G153, G154  
Phomopsis 
columnaris 
G117  
Batch 2 (greenhouse samples) 
OTU identification Fungal ID Compounds identified 
Phomopsis columnaris 
G117, G212, G214, 
G215, G216, G217, 
G218, G220, G221, 
G222, G223 
ergosterol peroxide (7),  
acremonidin C (11),  trichothecinol 
B with G217 (14), AGI-7 (15), (E)-
8-(3-(oct-2-enoyl)oxiran-2-
yl)octanoic acid (17), 5,8-
epidioxyergosta-6,9(11),22-trien-3-
ol (18)  
Ilyonectria robusta G213 
ergosterol peroxide (9), 
chermesinone A (16) 
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 Antimicrobial activity was measured for the compounds (3 and 6-9) that 
were isolated in sufficient quantity.  MIC and IC50 values for these compounds 
against Staphylococcus aureus and Pseudomonas aeruginosa are shown in 
Table 6.   None of the compounds were active against P. aeruginosa (MIC >200 
µg/mL).  Chaetocuprum A (3) inhibited growth of S. aureus (IC50 of 50 µg/mL), 
but complete growth inhibition was not achieved against this organism (MIC > 50 
µg/mL, which was the highest concentration tested).  The activity measured for 
equisetin (6) agreed with literature values, 1 µg/mL against S. aureus and no 
activity against P. aeruginosa.60  5'-epiequisetin (7) has not been previously 
evaluated for antimicrobial effects, and demonstrated an MIC of 1 µg/mL against 
S. aureus.  Palmitic acid (8) was found to be inactive probably due to its 
insolubility. The weak activity of ergosterol peroxide (9) against S. aureus (MIC of 
200 µg/mL) is in agreement with previous literature.61  The positive control for the 
antimicrobial assays was ciprofloxacin, which demonstrated an MIC of 0.25 
µg/mL against S. aureus and 0.125 µg/mL against P. aeruginosa, consistent with 
previous reports.62 
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 Structure Elucidation of Chaetocuprum A 
 The molecular formula of chaetocuprum A (3) was determined to be 
C24H33NO8 (9 unsaturations) on the basis of NMR and HRESIMS data.  
Inspection of the 1H NMR data (Tables 7 and 8 and figures 10-13) in CDCl3 and 
CD3OD revealed the presence of a methyl singlet, five methine signals including 
four oxymethines corresponding to two epoxide units, one olefinic proton, twenty-
two methylene protons, and one exchangeable proton. In addition to the signals 
consistent with above features, 13C NMR data indicated the presence of an 
oxygenated quaternary carbon, a non-protonated olefinic carbon, and four 
carbonyl carbons. 
 The 1H and 13C NMR signals (Tables 4 and 5) for H-6 (δH 3.65; J = 4.0), 
H-7 (δH 3.89; J = 4.0, 2.1), H-8 (δH 4.03; J = 4.0, 2.1), and H-9 (δH 3.58; J = 4.0) 
Table 6.  Minimum inhibitory concentration (MIC) and IC50 of select fungal 
metabolites against Staphylococcus aureus and Pseudomonas aeruginosa. 
 
Compound 
Staphylococcus 
aureus 
Pseudomonas aeruginosa 
 
MIC 
(µg/mL) 
IC50 
(µg/mL) 
MIC 
(µg/mL) 
IC50 (µg/mL) 
Chaetocuprum A (3) >50 50 >50 >50 
Equisetin (6) 1.0 0.5 >200 >200 
5’-Epiequisetin (7) 1.0 0.5 >200 >200 
Palmitic Acid (8) >200 >200 >200 >200 
Ergosterol peroxide 
(9) 
200 100 >200 >200 
Ciprofloxacin (+ 
control) 
0.25 0.125 0.125 0.0625 
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were diagnostic of a pair of the epoxide groups.  The adjacent location of two 
epoxide units was established by analysis of the 1H-1H COSY NMR data. HMBC 
correlations from H-6, H-8, and H-9 to C-10 (δC 196.7) supported the placement 
of epoxide units at a position alpha to the ketone carbon. HMBC correlations 
from H-6 to an oxygenated quaternary carbon (C-5; δC 84.7) and C-10 suggested 
the formation of a six-membered ring system.  Key HMBC correlations from 
methylene protons H2-4 (δH 2.94 and δH 2.49) to C-5, C-6 (δC 56.3), and C-10 
were consistent with the linkage to this group to C-5.  Additional correlations from 
H2-4 to an ester carbonyl carbon (C-2; δC 173.6) and the adjoining methine 
carbon (C-3; δC 48.9) in conjunction with the chemical shift of C-5 supported the 
presence of a lactone, resulting in the formation of a spirocycle.   
 Fortunately, HMBC correlations from an exchangeable proton NH (δH 
6.34) to C-3, C-1’ (δC 169.7), and C-2’ (δC 129.4) were also observed when data 
were collected in CDCl3 and established the linkage of amide group to C-3.  Key 
correlations from methyl group protons H3-15’ (δH 1.82) to C-1’, C-2’ (δC 129.4), 
and C-3’ (δC 139.3) extended the side chain to include an α, β-unstaurated olefin.  
A single spin system from H-3’ to H-13’ was identified primarily by analysis of the 
1H-1H COSY NMR data. The remaining NMR data was consistent with the 
presence of a ten-carbon aliphatic chain. A terminal carboxylic acid group (C-14’; 
δC 177.0) accounted for the remaining unsaturation and carbon count, thereby 
completing the assignment of the gross structure of 3 as shown.  Conclusive 
assignment of the overall relative configuration of chaetocuprin A (3) could be  
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made solely on the basis of NOESY data. Unfortunately, the crystallization 
attempts were also unsuccessful. 
Table 7.  NMR spectroscopic data (500 MHz for 1H NMR and 125 MHz for 13C NMR, 
CDCl3) for chaetocuprum A (3). 
 
no. δH (mult., J in Hz) δC (mult.) HMBC (H
# → C#) 
2  173.6 s  
3 4.25 (m) 48.9 d 2, 4, 5, 1' 
4 2.94 (dd, 10.2, 14.0) 
2.49 (dd, 10.2, 14.0) 
34.5 t 2, 3, 5, 6, 10 
2, 3, 5, 6, 10 
5  83.5 s  
6 3.65 (d, 4.0) 56.3 d 4, 5, 7, 8, 10 
7 3.89 (dd, 2.1, 4.0) 52.6 d 5, 6, 8, 9 
8 4.03 (dd, 2.1, 4.0) 57.9 d 6, 7, 9, 10 
9 3.58 (d, 4.0) 55.5 d 5, 7, 8, 10  
10  196.7 s  
1'  169.7 s  
2'  129.4 s  
3' 6.43 (t, 7.0) 139.3 d 1', 2', 4', 5', 15'  
4' 2.13 (m) 28.7 t 2', 3', 5', 6'  
5' 1.40 (t, 7.0) 29.0 t 3', 4', 7' 
6' 1.30 (m) 29.9 t  
7' 1.30 (m) 29.35 t  
8' 1.30 (m) 29.32 t  
9' 1.30 (m) 28.6 t  
10' 1.30 (m) 29.39 t  
11' 1.30 (m) 29.1 t  
12' 1.60 (m) 24.8 t 10', 14' 
13' 2.32 (t, 7.0) 33.7 t 11', 14' 
14'   177.0 s  
N-H 6.34 (d, 4.0)  2, 3, 4, 1', 2' 
15’ 1.82 (s) 12.7 q 1', 2', 3' 
39 
 
Table 8.  NMR spectroscopic data (400 MHz for 1H NMR and 100 MHz for 13C NMR, 
CD3OD) for chaetocuprum A (3). 
 
no. δH (mult., J in Hz) δC (mult.) HMBC (H
# → C#) 
2  175.3 s  
3 4.28 (m)  50.0 d 2, 4, 5, 1' 
4 2.76 (dd, 10.0, 13.8) 
2.53 (dd, 10.0, 14.8) 
34.1 t 2, 3, 5, 6, 10 
2, 3, 5, 6, 10 
5  84.7 s  
6 3.64 (d, 4.0) 57.4 d 4, 5, 7, 8, 10 
7 3.98 (dd, 2.0, 4.0) 53.9 d 5, 6, 8, 9 
8 4.12 (dd, 2.0, 4.0) 59.1 d 6, 7, 9, 10 
9 3.59 (d, 4.0) 56.6 d 5, 7, 8, 10  
10  199.1 s  
1'  171.8 s  
2'  131.0 s  
3' 6.40 (m) 139.3 d 1', 2', 4', 5', 15' 
4' 2.17 (m) 29.4 t 2', 3', 5', 6'  
5' 1.43 (t, 5.2) 29.9 t 3', 4', 7' 
6' 1.29 m 30.5 t  
7' 1.29 m 29.9 t  
8' 1.29 m 30.5 t  
9' 1.29 m 30.3 t  
10' 1.29 m 29.9 t  
11' 1.29 m 30.7 t  
12' 1.57 (t, 6.8) 26.2 t 10', 14' 
13' 2.25 (t, 7.2) 34.1 t 11', 14' 
14'   177.9 s  
N-H    
12.6 q 1.81 (s)  1', 2', 3' 
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Chemical shift in ppm 
Figure 10. 1H NMR spectrum of chaetocuprum A (3) (400 MHz, CDCl3). 
 
Chemical shift in ppm 
Figure 11. 13C NMR spectrum of chaetocuprum A (3) (100 MHz, CDCl3). 
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Chemical shift in ppm 
Figure 12. 1H NMR spectrum of chaetocuprum A (3) (400 MHz, CD3OD). 
Chemical shift in ppm 
Figure 13. 13C NMR spectrum of chaetocuprum A (3) (100 MHz, CD3OD). 
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 Fungal Compounds in an A. californica Extract? 
 It was of interest to determine whether any of the endophyte compounds 
(3, 5-18) in figures 7-9 could be detected in A. californica roots.  Towards this 
goal, a botanical extract was prepared from the same batch of A. californica roots 
from which the second batch of endophytes was isolated (Figure 6 and Table 4). 
This extract was analyzed using the LC-MS-MS procedure applied to the 
endophyte extracts, and the resulting chromatographic and mass spectrometric 
data were compared to that obtained from the fungal extracts.  With the 
exception of ergosterol peroxide (9), which is produced by many natural 
organisms including plants, fungi and some insects,54, 56, 63 none of the 
compounds (3, 5-18) shown in figures 7-9 were detected in the plant extract. This 
result is not particularly surprising, given that the fungal extracts were obtained 
from pure fungal cultures grown on rice, conditions that differ greatly from the 
natural environment of the plant root.  It is likely that culturing the fungi alters the 
abundance or identity of secondary metabolites produced.  Furthermore, many of 
the compounds reported herein as fungal metabolites were isolated from batch 1 
fungi, while the extract was prepared from the batch 2 roots (for which the only 
fungal species isolated were Phomopsis columnaris and Ilyonectria robusta). 
 As an alternative strategy towards identifying fungal compounds in the A. 
californica botanical extract, the LC-MS profiles obtained by analyzing this extract 
were searched against the aforementioned database of fungal compounds.57 As 
a result, five additional compounds (19-23) were identified in the botanical extract 
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that were not detectable in the fungal extract or control (rice extract).  These 
compounds were present at very low concentration, which prevented their 
isolation, but tentative identification was possible by matching LC-MS-MS data 
with that in the fungal library.57 The experimental design for this study involved 
grinding up entire A. californica roots (without surface sterilization) to prepare the 
botanical extract.  Thus, the compounds shown below could be produced by 
endophytic fungi, epiphytic fungi associated with the root surfaces, or by the plant 
itself.  However, literature precedent indicates these compounds to be of fungal 
origin.50, 64-67 
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Figure 14. Compounds tentatively identified from an A. 
californica extract by matching LC/MSMS fragmentation 
patterns with a database of high resolution mass 
spectrometry data on pure fungal compounds. Trichodermol 
(19), trans-dihydrowaol A (20), epi-Malettinin C (21), cis-
dihydrowaol A (22), 1-(2’-hydroxy-4’-methoxy-5’-
hydroxymethylphenyl)-E-4-hexen-1-one (23).  
 Compounds 19-23 in figure 14 have been reported to have an array of 
interesting biological activities.  Trichodermol (19) is classified as a trichothecene 
and is considered a mycotoxin and an antibacterial compound.64 Compounds 20 
and 22, trans and cis-dihydrowaol, are polypeptide-derived γ-lactones with 
furo[3,4-b]pyran-5-one bicyclic ring systems.65 This class of compounds does 
contain similar compounds that are fungicidal and antibacterial.66 Malettinin C-
NNP (21) is a polyketide-derived tropolone, and its epimer malettinin C inhibits 
growth of the fungus C. albicans, and bacteria S. aureus, and B. subtilis.50 1-(2’-
hydroxy-4’-methoxy-5’-hydroxymethylphenyl)-E-4-hexen-1-one (23) is in the 
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sorbicillin family of compounds, which have been shown to have antifungal 
activity against Fusarium verticillioides and Aspergillus flavus.67 Collectively, 
these literature reports suggest potentially interesting biological effects of the 
fungal compounds in the A. californica root extract. 
 Chemical Overlap Between Fungal Extracts and an A. californica    
      Extract 
 
 The previous section describes targeted analysis to identify fungal 
compounds in the A. californica root extract.  In addition, we asked the broader 
question of whether there was any chemical overlap between the A. californica 
root extract and the extracts of fungal endophytes cultured from those same 
roots.  Towards this goal, the relevant features from the LC-MS chromatograms 
from the fungal extracts and the botanical extract were identified using 
IntelliExtract, and these datasets were compared to identify compounds shared 
between the botanical and fungal extracts but not present in the control.  A series 
of eighteen compounds (Table 9) were detected with the same accurate mass, 
retention time, and MS-MS fragmentation spectrum in both the A. californica root 
extract and at least one fungal extract.  Figure 15 is an example chromatogram 
comparing fungal, rice, and botanical extracts.   The compounds listed in Table 9 
could be of either fungal or botanical origin, or both.  It is possible that both the 
fungi and the botanical (A. californica), produce some of the same compounds, 
either as a result of gene transfer or because of an independent, genetic 
development of biological pathways. Another likely explanation for the chemical 
overlap between fungal and botanical extracts is that endophytic fungi living in 
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the A. californica roots are extracted along with the plant roots.  Importantly, the 
approach used for fungal culture prevents cross-contamination of fungal extracts 
with botanical compounds.68 Thus, it is highly unlikely that overlap in chemistry 
between fungal and botanical extracts is an artifact of laboratory procedures.  
Fungi are isolated in a stepwise process and plant tissues are absent from the 
pure fungal cultures.  As support of the effectiveness of this approach for 
preventing contamination of fungal extracts with botanical tissues, the 
compounds sesamin (1) and asarinin (2), which have previously been shown to 
be highly abundant in A. californica root extracts,44 were not detected in any of 
the 15 fungal extracts based on the absence of the m/z and fragmentation 
patterns in the endophytic fungi.  
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Figure 15. Base peak chromatogram of m/z 509.28653 C27H44N3O6
- collected in the 
negative ion mode and normalized to a signal of 7.75 × 104.  RT represents the retention 
time (in min) AA represents the area of the peak, and BP is the measured mass of the 
ion that comprises the peak. A clear signal is observed for a pair of isomeric compounds 
at m/z 509.2853 in both the Hypocreales sp. endophyte extract and the Anemompsis 
californica root extract.  This signal is absent from the negative control, which is an 
extract of the medium on which the fungus was grown (rice).  These data indicate 
chemical overlap between the fungus and the botanical extract.   
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Table 9. Accurate masses, proposed formulae, and possible structures 
corresponding to features common to the endophytic fungal extracts and the 
A. californica botanical extract. 
 
Accurate 
mass 
Proposed 
formula 
Fungal sample Possible structure 
218.1664 C15H23O Phomopsis columnaris  
1,8-
Dihydroxyanthraquin
one; Mono-Me ether 
254.0566 C15H10O4 Phomopsis columnaris  
268.1667 C15H24O4 Phomopsis columnaris  
270.0524 C15H10O5 Phomopsis columnaris  
352.0949 C20H16O6 Phomopsis columnaris 
4,9-Dihydroxy-10,15-
botryanolide 
 
352.2616 C21H36O4 Phomopsis columnaris  
416.2309 C23H32N2O5 Phomopsis columnaris 
5,8-Epidioxyergosta-
6,22-dien-3-ol; 
(3β,5α,8α,22E,24R)-
form, Formyl 
 
448.2571 C24H36N2O6 Phomopsis columnaris  
456.3223 C29H44O4 Phomopsis columnaris  
460.3181 C28H44O5 Phomopsis columnaris  
479.2901 C26H41NO7 Phomopsis columnaris  
485.3491 C30H47NO4 Phomopsis columnaris  
495.3308 C27H45N3O6 Phomopsis columnaris  
505.3157 C27H43N3O6 Phomopsis columnaris  
506.3083 C25H46O10 Ilyonectria robusta  
510.2945 C38H38O Phomopsis columnaris  
596.2946 C41H40O4 Phomopsis columnaris  
608.4265 C35H60O8 Phomopsis columnaris  
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 The compounds listed in Table 9 as present in both the fungal and plant 
extracts were present at very low levels.  Isolation followed by structure 
elucidation was not achieved for any of them. However, three of the molecular 
formulae in Table 9 matched the structures of compounds previously reported 
from a fungus of the genus Phomopsis.69 These compounds were 1-Hydroxy-8-
methoxyanthraquinone ether (C15H10O4), 4β-acetoxy-9β-10β-15α-
trihydrixyprobotrydial (C15H24O4), and 22E, 24R-5α, 8α-epidioxyergosta-6, 22-
dien-3β-formate (C29H44O4).  Although identities of these compounds certainly 
cannot be confirmed by matching molecular formula with literature, the data are 
highly suggestive that these compounds (or isomers thereof) are present in the 
A. californica root extract.  The high frequency with which the fungal endophyte 
Phomopsis columnaris was isolated from the A. californica root extract supports 
this conclusion. 
 Relevance of the Studies for Ethnobotanical Use and Antimicrobial    
      Drug Discovery 
 
 This study casts some interesting light on the potential relevance (or lack 
thereof) of endophytes to the biological activity of a botanical medicine.  We have 
shown that A. californica, a plant traditionally used to treat infection, contains 
antimicrobial endophytes. We have also identified or isolated a number of 
antimicrobial compounds from A. californica endophytes, and have shown that 
there is potential overlap in the chemistry between a botanical extract and the 
fungi isolated from that extract (although the identities of the compounds that 
constitute that overlap remain unconfirmed).  Finally, we have shown that an 
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extract prepared from A. californica roots contains a number of compounds 
previously identified in fungi (19-23), many of which have interesting reported 
biological activities. 
 While it is tempting on the basis of our findings to implicate a causal 
relationship between the ethnobotanical use of A. californica and the biological 
activity of its endophytes, the current data are only correlative.  Furthermore, the 
plant extract alone did not possess antimicrobial activity against S. aureus or P. 
aeruginosa (data not shown), although it had previously been shown to inhibit the 
growth of various strains of mycobacteria.44 Additionally, the compounds 
identified as overlapping between the botanical and the endophytes were present 
at very low levels, estimated on the basis of LC-MS data to be in the range of 10 
to 100 ppm (expressed as mg of compound/kg of plant extract).  Finally, with the 
exception of ergosterol peroxide (9), the antimicrobial compounds identified in 
the fungal extracts were not detected in the A. californica root extract.  It is 
entirely possible, however, that plants grown in a different environment might 
contain higher levels of endophyte metabolites, or metabolites with more potent 
activity. 
 This study shows that a diverse array of metabolites is produced by 
endophytic fungi from A. californica, several of which are antimicrobial.  This 
finding is consistent with ample literature that shows fungi are an excellent 
source of antimicrobial compounds.70 Thus, even though the fungal endophyte 
profile of a given botanical is likely to vary a great deal depending on 
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environment, there is a high likelihood that any given sample will contain 
endophytes that produce antimicrobial compounds.  It can, therefore, be 
concluded that the practice of employing botanical preparations topically to treat 
infection is likely to result in the application of antimicrobial fungal metabolites as 
well as botanical components. Whether or not these will be present at 
therapeutically relevant levels remains to be established. 
 Regardless of their relevance to the ethnobotanical use of A. californica, 
these studies do show botanical endophytes to be a good source of antimicrobial 
natural products.  However, our findings also indicate that the richness of fungal 
diversity (and associated chemical diversity) obtained as a result of endophyte 
isolation can vary greatly depending on how and where the plant was cultivated.  
The diversity of antimicrobial compounds isolated or identified from the wild-
cultivated A. californica plants, which included the new compound chaetocuprum 
A (3), was far wider than that identified in the same plants after one year of 
cultivation in a greenhouse (Table 5).  Thus, natural products chemists seeking 
to isolate compounds from botanical endophytes should consider the potential 
impact of growing conditions of the botanical host on their drug discovery efforts.  
On a positive note, the phenomenon of different endophyte profile depending on 
environment could also be advantageous for drug discovery, as simply collecting 
plant material from different locations could harbor different chemistries. 
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Materials and Methods 
 General Experimental Procedures 
 The NMR spectra were recorded in both CDCl3 and CD3OD with 
references peaks (δH 7.24/ δC 77.2 for CDCl3 and δH 3.31/ δC 49.2 for CD3OD). 
NMR data were collected using JEOL ECA-500 and Joel ESC-400 NMR 
spectrometers.  The HRESIMS data was collected on a Thermo LTQ Orbitrap XL 
mass spectrometer.  A Teledyne CombiFlash ISCO with a RediSep Rf Gold® 
column (4 g silica 40 µm) was used for normal phase separations.  A Varian 
HPLC Prostar  (Thermo Fisher Scientific, Waltham, MA, USA) was used with a 
Gemini Phenomenex C18 column (5 µm, 120Å; 250 x 20 mm) (Phenomenex Inc, 
Torrance, CA, USA) and the Galaxie Chromatography Workstation Software 
(version 1.9.3.2) for reversed-phase preparative separations. Analytical 
separations were performed with a Gemini Phenomenex C18 column (5 µm, 
120Å; 250 x 20 mm).  For antimicrobial assays, the optical density at 600 nm was 
read using a POLARstar Optima microplate reader (BMG Labtech, Inc).  UV was 
measured by using a HPLC-Diode Array Detector (Agilent, Santa Clara, CA, 
USA).  Optical rotation was measured on a Rudolph Research Autopol III 
polarimeter  (Rudolph Research Analytical, Hackettstown, NJ, USA).  ECD was 
measured on an Olis DSM 17 CD spectrophotometer.  Müeller-Hinton broth, 
ciprofloxacin (purity >98% by HPLC), and palmitic acid (purity >99% by HPLC) 
were purchased from Sigma Aldrich.  Other reagents were purchased from 
Fisher Scientific. 
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 Plant Material 
 Anemopsis californica plants were collected by Amy Brown of Apache 
Creek Ranch in Sante Fe, NM (35°35' 56.40"N, 105°50' 27.22W).  The plants 
were taken from their native environment in New Mexico.  A voucher specimen 
(NCU602027) was deposited in the University of North Carolina Herbarium, and 
was authenticated by Amy Brown.  Fungi were isolated from surface sterilized 
fresh root samples, and the remaining material was air dried at 37°C before 
extraction. 
 Endophyte Isolation and Identification 
 Isolation of fungal endophytes was performed using methods outlined 
previously.68, 71 For molecular identification of fungal endophytes isolated from 
yerba mansa, the internal transcribed spacer region of the ribosomal RNA gene 
(ITS) was sequenced using methods described formerly.65, 68, 71, 72  The ITS 
sequences from all strains were deposited in the GenBank (accession no XXX). 
Anemopsis californica Extraction 
 A 1.0 kg lot of dried Anemopsis californica root material (from batch #2) 
was ground using a Bel-Art Scienceware Micro-Mill Grinder (Fisher Scientific, 
Waltham, MA USA) and percolated in MeOH overnight.  The MeOH extract was 
evaporated to dryness under vacuum.  This procedure was repeated with the 
same root material until there was no color remaining in the methanol. The 
methanol extract was then dried under vacuum and subjected to liquid-liquid 
extraction, as described previously.35 The resulting residue was exhaustively 
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partitioned with hexane and 10% aqueous MeOH (1:1) until no color remained in 
the hexane layer.  The dried aqueous MeOH fraction was partitioned further 
between 4:1:5 CHCl3:MeOH:H2O.  The residue obtained by rotary evaporation of 
the CHCl3 layer was retained for testing and analysis. 
 Endophyte Culture and Extraction 
 A solid, grain-based media was used to grow small-scale cultures of fungi 
in 250 mL Erlenmeyer flasks as previously described.73 Each fungal culture was 
chopped and shaken overnight (16 hr at 100 rpm) in a 1:1 MeOH-CHCl3 solution, 
subjected to vacuum filtration, and washed with small volumes of MeOH.  The 
filtrate was stirred in a 3:5 ratio of CHCl3 H2O for 2 hr.  After separating the 
organic and aqueous layers, both layers were evaporated to dryness under 
vacuum.  The organic layer was then resuspended in a 1:1:1 mixture of 
MeOH:CH3CN:hexane.  The MeOH:CH3CN and hexane layers were separately 
dried under vacuum.  The residue from the MeOH:CH3CN layer was used for 
bioassays, dereplication, isolation, and chemical profile comparison between the 
endophytes and the A. californica extract.  A separate extraction was also 
conducted using identical conditions with just the rice medium (no fungus) as a 
negative control. 
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Isolation 
 The isolation schemes are provided as in figures 16 and 17.  The first 
stage of normal-phase flash chromatography (4 g silica gel column) was 
conducted at a 18 mL/min flow rate with a 35 min hexane:CHCl3:MeOH gradient.  
The first stage separations of Chaetomium cupreum (G118) and Cylindrocarpon 
sp. (G120) were conducted under the same conditions.  In the first stage of 
separation for Chaetomium cupreum (G118, Figure 16), ergosterol peroxide (9) 
eluted at 29 min in fraction 4 (7 mg, 97.2 % purity, 0.0028% yield).   
 Fraction 2 was subjected to a second stage of purification using a 
reversed phase preparative HPLC with a Gemini BEH C18 column at a 21 
mL/min flow rate.  A linear ACN:H2O gradient starting from 30:70 to 90:10 over 
20 min yielded cochliodone A (5) with a 17 min retention time (1 mg, 98 % purity, 
0.0004% yield).  Fraction 3 was also subjected to the same gradient, and 
produced sub-fraction 2.  This fraction was then purified with an isocratic solvent 
composition of 50:50 ACN: H2O on a preparative HPLC with a Gemini BEH C18 
column at a 21 mL/min flow rate over 20 min.  Compound 3, chaetocuprum A, 
eluted at 16 min (13 mg, 98.5 % purity, 0.0052% yield). In the first stage of 
separation for Cylindrocarpon sp. (G120, Figure 17), palmitic acid (8) eluted at 
32.5 min in fraction 4 (27 mg, 97.0 % purity, 0.011% yield).  Fraction 3 was close 
to two pure compounds; therefore it went through a second stage of purification 
using a reversed phase preparative HPLC with a Gemini BEH C18 column at a 
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21mL/min in 20 min yielded equisetin (6) at 12 min (45 mg, 98 % purity, 0.018% 
yield) and 5’- epiquisetin (7) at 12.7 min (25 mg, 98 % purity, 0.010% yield). 
 
 
 
 
 
 
 
 
Figure 16. Isolation scheme of chaetocuprin A (3), cochliodone A (5), ergosterol 
peroxide (9) from Chaetomium cupreum (G118). 
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Figure 17. Isolation scheme of equisetin (6), 5'-epiequisetin (7), and palmitic acid (8) 
from Cylindrocarpon sp. (G120). 
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Chaetocuprum A (3): green oil; HRESIMS obsd. m/z 464.2268 [M+H]+, 
calcd for C24H34NO8
+, 464.2284, 24.5
D
= - 28.6 (c 0.07 MeOH); ECD in 
methanol at 214 nm 29.3°, at 230 nm -8.5°, and at 297 nm -8.1°,  
UV (Methanol) λmax (log ϵ) 226 (2.62) nm. 
Cochliodone A (5): green solid; HRESIMS m/z 639.2427 [M+H]+ (calcd for 
C34H39O12
+, 639.2436). 1H NMR (500 MHz CDCl3) and 
13C NMR (125 MHz 
CDCl3) data were in agreement with literature.
51 
Equisetin (6): colorless solid; HRESIMS m/z 374.2322 [M+H]+ (calcd for 
C22H32NO4
+, 374.2326); 1H NMR (500 MHz CDCl3) and 
13C NMR (125 MHz 
CDCl3) chemical shifts were in agreement with literature values.
74 
5′-epiequisetin (7): colorless solid; HRESIMS m/z 374.2323 [M+H]+ (calcd 
for C22H32NO4
+, 374.2326); 1H NMR (500 MHz CDCl3) and 
13C NMR (125 MHz 
CDCl3) were in agreement with literature values.
74 
Palmitic acid (8): white solid; HRESIMS m/z 256.2402 [M-H]- (calcd for 
C16H22O2, 256.2402). 
1H NMR (500 MHz CDCl3) and 
13C NMR (125 MHz CDCl3) 
data were in agreement with literature75 GCMS was performed to identify the 
fatty acid with 95% accuracy based on matching with the NIST database. In 
addition, LC-MS retention time and fragmentation for this compound matched 
that of a synthetic standard (Sigma Alrich > 99% purity by HPLC). 
Ergosterol peroxide (9): green solid; HRESIMS m/z 429.33652 [M+H]+ 
(calcd for C28H45O3
+, 429.3363). 1H NMR (500 MHz CDCl3) and 
13C NMR (125 
MHz CDCl3) data were in agreement with literature.
76 
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LC-MS Data Collection and Analysis 
 Each crude fungal endophyte extract, the A. californica extract, and the 
rice extract control were analyzed with LC-MS in the positive and negative ion 
modes, using a method described previously.57 Briefly, separation was achieved 
using a CH3CN-H2O (0.1 % formic acid) mobile phase gradient. Fungal 
metabolites were identified on the basis of accurate mass measurements, 
retention time, and collisionally induced dissociation (CID) fragmentation by 
matching with a fungal dereplication database. To collect the MS data for 
comparison with the dereplication database, two scan events were performed, 
full scan (100-2000) and CID of the most intense ion from a list of possible 
precursor masses described previously.57 Each LC-MS chromatogram was 
analyzed with ACD IntelliXtract (Toronto, Ontario, Canada).  Data sets were 
compared to fungal secondary metabolite library previously reported.57 In 
addition, IntelliXtract allows for the comparison of two chromatograms to 
determine which features are shared between two different samples. To identify 
features specifically attributable to the fungus, the LC-MS data for each fungal 
extract was compared to this negative control (rice extract) and features shared 
between the two samples were eliminated. IntellliXtract was then used to identify 
features shared between the extracts from each endophytic fungus and the A. 
californica extract. Each feature identified as being shared between the botanical 
extract and a given fungal extract (but not present in the rice control) was then 
manually checked by comparing selected ion chromatograms (Figure 15) to 
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verify the accuracy of the IntelliXtract data.  The threshold set for comparison 
was a peak area of at least 1 × 105. 
Antimicrobial Assays 
 Broth microdilution assays to evaluate antimicrobial susceptibility were 
performed according to Clinical Laboratory Standards Institute (CLSI) 
guidelines.77 S. aureus (strain NCTC 8325-4),78 and P. aeruginosa (strain NCTC 
NCTC 12903) were used for biological testing.  In separate experiments, single 
colony inocula of S. aureus or P. aeruginosa were grown to log phase in Müeller-
Hinton broth and were adjusted to a final assay dilution of 1.0 x 105 CFU/mL 
based on OD600 of 0.11 for both bacteria.  The negative control consisted of 2% 
DMSO in broth (vehicle) and ciprofloxacin served as the positive control.  All 
treatments and controls were prepared in triplicate wells.  For background 
subtraction, additional wells were included containing the samples without 
bacteria.  OD600
 was measured after incubation for 18 hrs at 37 ˚C.  MIC was 
defined as the concentration at which no statistically significant difference was 
observed between the negative control and treated samples.  IC50 was defined 
as the concentration at which there is a 50% decrease in growth observed 
between the negative control and the treated samples. 
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CHAPTER IV 
CONCLUSION 
 Goal 1 was accomplished by identifying sesamin (1) and asarinin (2) from 
Anemopsis californica as compounds effective in vitro against non-tuberculosis 
mycobacterial infections.  Goal 2 was completed by isolating antimicrobial 
compounds from the fungi and then comparing the chemical composition of the 
fungal extract to that of the A. californica plant extract. In addition the plant 
contained compounds of fungal origin, and endophytic fungal diversity depended 
on the environment in which the plant is grown. Future studies will entail 
collecting medicinal plants from different populations, isolating the endophytic 
fungi, and then comparing the chemical profiles of the fungal extracts to each 
other.  If plants with do contain a more diverse population of endophytic fungi, it 
may be possible to see an overlap in the antimicrobial compounds produced by 
the endophytic fungi.  In addition, there is still the question of whether the plant or 
the endophyte makes the secondary metabolites.  To truly answer this question, 
the plant should be made endophyte free and then inoculated with fungal 
endophytes previously identified to live within A. californica.  In order to do this, a 
plant seed would have to be sterilized and grown to maturity in a nutrient rich 
medium with antifungal compounds.  In addition, DNA markers testing for certain 
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fungi would have to be collected to see if the plants are truly endophyte free.  
This process would be very hard to perform and would take a lot of time. 
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